Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies

IF 4.7 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-04-01 DOI:10.1089/hs.2023.0099
Diane L Downie, Preetika Rao, Corinne David-Ferdon, Sean Courtney, Justin S Lee, Claire Quiner, Pia D M MacDonald, Keegan Barnes, Shelby Fisher, Joanne L Andreadis, Jasmine Chaitram, Matthew R Mauldin, R. Salerno, Jarad Schiffer, Adi V Gundlapalli
{"title":"Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies","authors":"Diane L Downie, Preetika Rao, Corinne David-Ferdon, Sean Courtney, Justin S Lee, Claire Quiner, Pia D M MacDonald, Keegan Barnes, Shelby Fisher, Joanne L Andreadis, Jasmine Chaitram, Matthew R Mauldin, R. Salerno, Jarad Schiffer, Adi V Gundlapalli","doi":"10.1089/hs.2023.0099","DOIUrl":null,"url":null,"abstract":"The surveillance and identification of emerging, reemerging, and unknown infectious disease pathogens is essential to national public health preparedness and relies on fluidity, coordination, and interconnectivity between public and private pathogen surveillance systems and networks. Developing a national sentinel surveillance network with existing resources and infrastructure could increase efficiency, accelerate the identification of emerging public health threats, and support coordinated intervention strategies that reduce morbidity and mortality. However, implementing and sustaining programs to detect emerging and reemerging pathogens in humans using advanced molecular methods, such as metagenomic sequencing, requires making large investments in testing equipment and developing networks of clinicians, laboratory scientists, and bioinformaticians. In this study, we sought to gain an understanding of how federal government agencies currently support such pathogen agnostic testing of human specimens in the United States. We conducted a landscape analysis of federal agency websites for publicly accessible information on the availability and type of pathogen agnostic testing and details on flow of clinical specimens and data. The website analysis was supplemented by an expert review of results with representatives from the federal agencies. Operating divisions within the US Department of Health and Human Services and the US Department of Veterans Affairs have developed and sustained extensive clinical and research networks to obtain patient specimens and perform metagenomic sequencing. Metagenomic facilities supported by US agencies were not equally geographically distributed across the United States. Although many entities have work dedicated to metagenomics and/or support emerging infectious disease surveillance specimen collection, there was minimal formal collaboration across agencies.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"238 ","pages":"85 - 92"},"PeriodicalIF":4.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/hs.2023.0099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 1

Abstract

The surveillance and identification of emerging, reemerging, and unknown infectious disease pathogens is essential to national public health preparedness and relies on fluidity, coordination, and interconnectivity between public and private pathogen surveillance systems and networks. Developing a national sentinel surveillance network with existing resources and infrastructure could increase efficiency, accelerate the identification of emerging public health threats, and support coordinated intervention strategies that reduce morbidity and mortality. However, implementing and sustaining programs to detect emerging and reemerging pathogens in humans using advanced molecular methods, such as metagenomic sequencing, requires making large investments in testing equipment and developing networks of clinicians, laboratory scientists, and bioinformaticians. In this study, we sought to gain an understanding of how federal government agencies currently support such pathogen agnostic testing of human specimens in the United States. We conducted a landscape analysis of federal agency websites for publicly accessible information on the availability and type of pathogen agnostic testing and details on flow of clinical specimens and data. The website analysis was supplemented by an expert review of results with representatives from the federal agencies. Operating divisions within the US Department of Health and Human Services and the US Department of Veterans Affairs have developed and sustained extensive clinical and research networks to obtain patient specimens and perform metagenomic sequencing. Metagenomic facilities supported by US agencies were not equally geographically distributed across the United States. Although many entities have work dedicated to metagenomics and/or support emerging infectious disease surveillance specimen collection, there was minimal formal collaboration across agencies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在美国利用病原体无差别元基因组测序监测新发和再发病原体:联邦政府机构的关键作用
对新出现、再次出现和未知传染病病原体的监测和识别对国家公共卫生准备工作至关重要,并有赖于公共和私营病原体监测系统和网络之间的流动性、协调性和互联性。利用现有资源和基础设施建立国家定点监测网络可以提高效率,加快识别新出现的公共卫生威胁,并支持协调干预策略,从而降低发病率和死亡率。然而,要实施和维持使用先进分子方法(如元基因组测序)检测人类新发和再发病原体的计划,需要对检测设备进行大量投资,并建立由临床医生、实验室科学家和生物信息学家组成的网络。在这项研究中,我们试图了解美国联邦政府机构目前是如何支持这种不考虑病原体的人体标本检测的。我们对联邦机构网站进行了全面分析,以获取有关病原体不可知论检验的可用性和类型的公开信息,以及临床标本和数据流的详细信息。在对网站进行分析的同时,我们还与联邦机构的代表一起对分析结果进行了专家评审。美国卫生与公众服务部和退伍军人事务部的业务部门已经开发并维持了广泛的临床和研究网络,以获取病人标本并进行元基因组测序。美国各机构支持的元基因组设施在美国的地理分布并不均衡。虽然许多实体都有专门从事元基因组学和/或支持新发传染病监测标本收集的工作,但各机构之间的正式合作却少之又少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊介绍: ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.
期刊最新文献
Mesoporous Silica Nanoparticles: A Promising Nanoplatform for Treating Osteoarthritis and Rheumatoid Arthritis. NIR-Activated Bactericidal-Antioxidative Microneedles Based on Organic J-Aggregates to Accelerate Infected Wound Healing. Retraction of "Real-Time Monitoring of Mitochondrial pH in HeLa Cells, Drosophila melanogaster, and Zebrafish Larvae Using BODIPY-Based Ratiometric Fluorescent Probes". Correction to "Systemic microRNA Delivery Using Polysaccharide-Coated Nanobubbles for Ultrasound-Mediated Therapy of Triple-Negative Breast Cancer". Green Marine Collagen-Chitosan Composites with Biocompatible, Hemostatic, and Pro-Healing Performance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1